NCT05732012 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Greydanus DE, Pratt HD, Patel DR
Concepts of contraception for adolescent and young adult women with chronic illness and disability. Dis Mon. 2012 May;58(5):258-320. doi: 10.1016/j.disamonth.2012.02.001.
Huurre T, Aro H
The psychosocial well-being of Finnish adolescents with visual impairments versus those with chronic conditions and those with no disabilities. Journal of Visual Impairment and Blindness.2000;94:625-637.
Karaca S, Özaltin G
Experience with Structural Group Process: What Does a Group Process Executed with Blind Adolescents Teach?. Journal of Psychiatric Nursing. 2010; 1(2): 77-85.

Effectiveness of Online Sexual Health Psychoeducation Program Given to Physically Disabled Adolescents on Sexual Health Attitudes

Clinical trial NCT05732012 - References